Primary Health Properties (LON:PHP – Get Free Report)‘s stock had its “house stock” rating reaffirmed by analysts at Shore Capital Group in a research report issued to clients and investors on Friday,London Stock Exchange reports.
Several other equities research analysts also recently commented on the stock. JPMorgan Chase & Co. boosted their target price on shares of Primary Health Properties from GBX 100 to GBX 105 and gave the stock a “neutral” rating in a research report on Wednesday, April 8th. Stifel Nicolaus reiterated a “buy” rating and set a GBX 105 price target on shares of Primary Health Properties in a research note on Wednesday, April 15th. Jefferies Financial Group reissued a “buy” rating and set a GBX 118 price objective on shares of Primary Health Properties in a report on Thursday, July 2nd. Berenberg Bank reissued a “buy” rating and issued a GBX 128 price objective on shares of Primary Health Properties in a research note on Friday, April 24th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a GBX 115 target price on shares of Primary Health Properties in a report on Thursday, June 25th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Primary Health Properties presently has a consensus rating of “Moderate Buy” and an average target price of GBX 114.20.
Get Our Latest Analysis on PHP
Primary Health Properties Stock Performance
About Primary Health Properties
PHP invests in flexible, modern properties for local primary healthcare.
The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation.
To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a government body.
Further Reading
- Five stocks we like better than Primary Health Properties
- Palantir’s Wild Ride: Inside the Stock Wall Street Can’t Agree On
- Has Broadcom Become Too Expensive for Its AI Story?
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
Receive News & Ratings for Primary Health Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Primary Health Properties and related companies with MarketBeat.com's FREE daily email newsletter.
